Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039805
Filing Date
2020-07-01
Accepted
2020-07-01 17:13:10
Documents
1
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3979
  Complete submission text file 0001209191-20-039805.txt   5476
Mailing Address 5425 WISCONSIN AVE CHEVY CHASE MD 20815
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 201006042

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)